Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Evogene (EVGN) Net Margin (2016 - 2025)

Historic Net Margin for Evogene (EVGN) over the last 14 years, with Q3 2025 value amounting to 1241.67%.

  • Evogene's Net Margin rose 16801700.0% to 1241.67% in Q3 2025 from the same period last year, while for Sep 2025 it was 52.33%, marking a year-over-year increase of 2782300.0%. This contributed to the annual value of 295.59% for FY2024, which is 1278000.0% up from last year.
  • Evogene's Net Margin amounted to 1241.67% in Q3 2025, which was up 16801700.0% from 504.75% recorded in Q2 2025.
  • In the past 5 years, Evogene's Net Margin ranged from a high of 2827.24% in Q2 2022 and a low of 5039.74% during Q3 2021
  • Over the past 5 years, Evogene's median Net Margin value was 895.7% (recorded in 2024), while the average stood at 1083.37%.
  • Its Net Margin has fluctuated over the past 5 years, first plummeted by -65542900bps in 2021, then soared by 74272400bps in 2022.
  • Over the past 5 years, Evogene's Net Margin (Quarter) stood at 2370.1% in 2021, then surged by 81bps to 454.24% in 2022, then crashed by -151bps to 1142.04% in 2023, then soared by 102bps to 26.51% in 2024, then skyrocketed by 4585bps to 1241.67% in 2025.
  • Its Net Margin was 1241.67% in Q3 2025, compared to 504.75% in Q2 2025 and 105.85% in Q1 2025.